Results 21 to 30 of about 10,703 (208)

Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events [PDF]

open access: yes, 2020
Terbinafine is an antifungal agent used in the treatment of hair, nail, and skin dermatophyte infections. Skin side effects to terbinafine are not common.
Calame, Antoanella   +4 more
core   +1 more source

Comparative Study of Topical 1% Terbinafine Cream Versus 1% Clotrimazole Cream in The Treatment of Tineapedis

open access: yesDiyala Journal of Medicine, 2023
Background:Tinea pedis (athletic foot) is the most common dermatophytic fungal infection of the body. It may last for a short or long time and may recur after treatment.
Araz Hasan Mohammed,   +1 more
doaj   +1 more source

Antifungal Susceptibility Pattern of Non - Dermatophytic Fungi Causing Onychomycosis

open access: yesNepal Journal of Dermatology, Venereology & Leprology, 2020
Introduction: Non-dermatophytic molds (NDM) are filamentous fungi or yeast, commonly found in nature as saprophytes and plant pathogens. The incidence of onychomycosis due to NDM is 1.45 – 16.6%.
Apurva Kaushal   +5 more
doaj   +3 more sources

The Effect of Terbinafine and Its Ionic Salts on Certain Fungal Plant Pathogens

open access: yesMolecules, 2023
Terbinafine, an inhibitor of squalene epoxidase in ergosterol biosynthesis, is chiefly utilized as an antifungal medication with potential uses in pesticide applications.
Tao Wang   +4 more
doaj   +1 more source

The use and mechanism of action of terbinafine compared to other antifungal drugs used in the pharmacotherapy of candidiasis [PDF]

open access: yesFarmacja Polska, 2021
Terbinafine as an antifungal drug was introduced to the world market in 1991, which was a great advance in dermatology. From that time to 1999, it was used orally with good results in over 10 million people and locally in over 30 million.
Piotr Mariusz Dwiecki   +2 more
doaj   +1 more source

Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis

open access: yesIndian Journal of Dermatology, 2017
Introduction: Dermatophytosis are the most common fungal infections globally. Terbinafine is considered to have good potency against dermatophytes, but resistance to terbinafine is on the rise.
P Ravindra Babu   +5 more
doaj   +1 more source

Investigation on utility of some novel terpenes on transungual delivery of terbinafine for the management of onychomycosis

open access: yesDermatology Practical & Conceptual, 2022
Introduction: Onychomycosis is a fungal disorder of the nail which afflicts 5% of the population worldwide. The disease is strenuous to cure as it is chronic, hard to eliminate and tends to recur. Topical therapy is at the forefront for the treatment of
Isha Gupta   +4 more
doaj   +1 more source

In vitro Activity of Allicin Alone and in Combination With Antifungal Drugs Against Microsporum canis Isolated From Patients With Tinea Capitis

open access: yesFrontiers in Medicine, 2021
The checkerboard broth method based on the Clinical and Laboratory Standards Institute M38-A3 document was used in this study to evaluate the in vitro activity of allicin alone and in combination with the antifungal drugs (griseofulvin, fluconazole ...
Ya Bin Zhou   +3 more
doaj   +1 more source

Effect of Terbinafine on the Pharmacokinetics of Cyclosporin in Humans [PDF]

open access: yes, 1994
Cyclosporin is largely metabolized by hepatic cytochrome P450 enzymes, and azole drugs that inhibit cytochrome P450 may precipitate cyclosporin toxicity. The allylamine terbinafine binds to a small subfraction of hepatic cytochrome P450 in type I fashion,
Kendall, Francis   +6 more
core   +1 more source

The Influence of Oral Terbinafine on Gut Fungal Microbiome Composition and Microbial Translocation in People Living with HIV Treated for Onychomycosis

open access: yesJournal of Fungi, 2023
People living with HIV (PLWH) display altered gut epithelium that allows for the translocation of microbial products, contributing to systemic immune activation.
Jing Ouyang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy